TP-10

TP-10 is a selective PDE10A inhibitor with an IC 50 value of 0.8 nM. TP-10 shows an antioxidant activity with IC 50 s of 31.72 and 16.04 μg/ml for DPPH and CUPRAC, respectively. TP-10 can be used for the research of neuropathy In Vitro TP-10 (10 μg /mL; 24 h) affects total reactive oxygen species in human brain-derived cells (U-87 MG). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: U-87 MG cells Concentration: 10 μg/ml Incubation Time: 24 hours Result: Decreased the total number of ROS-positive cells and showed no toxic effects to U-87 MG cells. In Vivo TP-10 (0.1-10 mg/kg; i.h. once) shows an effect on cyclic nucleotides. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male CD ratsDosage: 0.1, 0.32, 1.0, 3.2 and 10 mg/kg Administration: Subcutaneous injection; 0.1-10 mg/kg once Result: Dose- and time-dependently increased the levels of both cGMP and cAMP in striatal of mice. Increased pCREB-LI level first and returned to basal levels after injected for 3 hours at a dose of 3.2 mg/kg. Form:Solid IC50& Target:IC50: 0.8 nM (PDE10A), 31.72 μg/mL (DPPH), 16.04 μg/mL (CUPRAC)

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet